Pros | Lower expense ratio. Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 5/8 | 3/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 7 Years | 7 Years | ||
Fund Size | 2762 Cr | 6227 Cr | ||
Min Investment | SIP ₹99 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.47% | 1.03% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 33 | 43 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (11.57%) Divi's Laboratories Ltd (7.76%) Glenmark Pharmaceuticals Ltd (6.97%) Apollo Hospitals Enterprise Ltd (6.23%) Cipla Ltd (6.03%) | Sun Pharmaceuticals Industries Ltd (11.58%) Dr Reddy's Laboratories Ltd (9.1%) Divi's Laboratories Ltd (8.75%) Aurobindo Pharma Ltd (8.25%) Cipla Ltd (6.92%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (98.61%) Basic Materials (1.39%) | Health (97.7%) Basic Materials (1.18%) Financial Services (1.12%) | ||
Equity % | 99.89% | 97.55% | ||
Debt % | - | - | ||
P/E | 38.6 | 30.65 | ||
P/B | 5.59 | 4.17 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 2.3% | 2.48% | ||
3-Month Return | 0.72% | 0.92% | ||
6-Month Return | 7.39% | 9.62% | ||
1-Year Return | 2.45% | 6.24% | ||
3-Year Return | 22.15% | 27.76% | ||
5-Year Return | 19.42% | 21.64% |
Sharpe | 0.91 | 1.26 | ||
Alpha | -1.17 | 4.3 | ||
Beta | 1 | 0.95 | ||
Standard Deviation | 16.46 | 15.69 | ||
Information Ratio | -0.53 | 1.4 |
Description | Mirae Asset Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Vrijesh Kasera | Dharmesh Kakkad,Sharmila D’mello |